Tax
Deferred Income Tax Expense
Amgen Deferred Income Tax Expense decreased by 826.3% to -$176.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.6%, from -$250.00M to -$176.00M. Over 4 years (FY 2021 to FY 2025), Deferred Income Tax Expense shows a downward trend with a 12.3% CAGR.
Analysis
StatementIncome Statement
SectionTax
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Large deferred tax assets or liabilities indicate significant differences between book income and taxable income, often due to depreciation or tax credits.
Detailed definition
The portion of income tax expense that is not currently payable but is expected to be paid or recovered in future period...
Peer comparison
Standard accounting metric for all corporations subject to income tax.
Metric ID:
ms_deferred_income_tax_expenseHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$46.00M | -$127.00M | -$189.00M | -$251.00M | -$263.00M | -$333.00M | -$351.00M | -$49.00M | -$154.00M | -$447.00M | -$623.00M | -$401.00M | -$383.00M | -$110.00M | -$334.00M | -$250.00M | -$422.00M | -$30.00M | -$19.00M | -$176.00M |
| QoQ Change | — | -176.1% | -48.8% | -32.8% | -4.8% | -26.6% | -5.4% | +86.0% | -214.3% | -190.3% | -39.4% | +35.6% | +4.5% | +71.3% | -203.6% | +25.1% | -68.8% | +92.9% | +36.7% | -826.3% |
| YoY Change | — | — | — | — | -471.7% | -162.2% | -85.7% | +80.5% | +41.4% | -34.2% | -77.5% | -718.4% | -148.7% | +75.4% | +46.4% | +37.7% | -10.2% | +72.7% | +94.3% | +29.6% |
Range-$623.00M – -$19.00M
CAGR+32.6%
Avg YoY Growth-76.9%
Median YoY Growth+9.7%
Deferred Income Tax Expense at Other Companies
Frequently Asked Questions
- What is Amgen's deferred income tax expense?
- Amgen (AMGN) reported deferred income tax expense of -$176.00M in Q1 2026.
- How has Amgen's deferred income tax expense changed year-over-year?
- Amgen's deferred income tax expense increased by 29.6% year-over-year, from -$250.00M to -$176.00M.
- What is the long-term trend for Amgen's deferred income tax expense?
- Over 4 years (2021 to 2025), Amgen's deferred income tax expense has grown at a 12.3% compound annual growth rate (CAGR), from -$453.00M to -$721.00M.
- What does deferred income tax expense mean?
- Tax costs that are deferred to future periods due to accounting timing differences.